🇺🇸

Broad Market

· monthly

US Pre-Market SEC Filings Roundup — September 01, 2026

Overnight SEC filings from August 31 to September 1, 2026, reveal a mixed market landscape with notable insider trading patterns and significant corporate actions. Key themes include a wave of insider selling by executives at Lyft, Oddity Tech, Xenon Pharmaceuticals, and Sea Ltd, contrasting with insider buying at Grocery Outlet, Hyperscale Data, and 17 Education & Technology Group. The most material developments include Regis Corp's mixed fiscal year results showing revenue growth but franchise declines, XTI Aerospace's Nasdaq deficiency notice with going concern risk, and the SPAC merger of Bleichroeder Acquisition Corp. III with Ursa Major Technologies. Capital allocation trends show Equinor and News Corp continuing buyback programs, while Mizuho Financial Group announced a significant ¥200 billion buyback. The IPO pipeline remains active with Capstone 72 and Entrata filing registration statements. Overall, the filings suggest cautious optimism in select sectors, with particular risks in small-cap and distressed companies.

28 high priority 22 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 31, 2026

The August 31, 2026, filing period is dominated by significant M&A activity and strategic capital allocation moves, with three major acquisitions totaling over $21 billion announced (Aon's $17B purchase of USI, ONEOK's $4.425B Brazos Midstream deal, and Ranger Energy's $27.5M coiled tubing acquisition). A clear sector theme emerges in energy and infrastructure, where companies are deploying capital for growth while simultaneously strengthening balance sheets. Several leadership transitions were announced across a broad range of companies, creating both uncertainty and opportunity. The period also saw a notable negative event with Northann Corp receiving a delisting notice, and a positive development with Trilogy Metals securing a strategic $35.6M investment from the U.S. Department of War. Period-over-period comparisons reveal a mixed picture: GameStop's operating income surged 126% YoY despite a 19% sales decline, while Zedge's free cash flow grew 55% YoY. Insider activity was limited but notable, with Zedge's Vice Chairman leading a $7.5M insider investment. Forward-looking guidance was generally positive, with Kyntra Bio extending its cash runway into Q4 2027 and TELA Bio targeting $17M in annual cost savings.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 31, 2026

This digest covers 50 filings from August 31, 2026, dominated by a wave of corporate control events, insolvencies, and regulatory actions. The most critical theme is a surge in M&A and open offers, particularly the high-profile acquisition of Tribhovandas Bhimji Zaveri (TBZ) by GRT Jewellers, which includes a mandatory open offer at a 19.4% premium, and the transformative merger of Happiest Minds Technologies into ITC Infotech, a deal valued at over ₹1,329 Cr for the initial stake. Concurrently, several companies are in advanced stages of financial distress, with Siti Networks (₹1,500 Cr default), MT Educare, and Punj Lloyd all under Corporate Insolvency Resolution Process (CIRP), signaling a peak in the credit cycle for stressed assets. Delisting actions are also prominent, with Cambium Networks and SES AI Corp facing final delisting, while Northann Corp is appealing a similar fate. The data reveals a bifurcated market: aggressive capital deployment by acquirers like GRT and ITC Infotech, contrasted with severe liquidity crises and regulatory non-compliance among smaller and mid-cap entities. Period-over-period comparisons, where available, show declining revenues and losses at subsidiaries like IIRM Global, reinforcing the stress theme. The overall sentiment is mixed, with high-conviction M&A providing bullish signals for target company shareholders, while the numerous defaults and delistings present significant risks.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 31, 2026

Today's filings reveal a market bifurcated between aggressive M&A and capital deployment by large-cap firms (Aon's $17B acquisition of USI, SLB's $3.4B acquisition of Kelvion) and significant distress signals from micro-cap companies facing delisting, dilution, and internal control failures. Period-over-period data shows a mixed earnings picture: SAIC posted 6% revenue growth but a 20% net income decline, while GameStop's operating income surged 126% YoY on a one-time gain, masking a 20% sales drop. Insider activity is a key theme, with multiple Sea Ltd executives selling over $2.7M combined under 10b5-1 plans, contrasting with bullish insider buying at Agree Realty ($1.46M) and Alzamend Neuro ($109K). Capital allocation trends are divergent, with BBVA actively buying back shares and Aon prioritizing debt repayment, while Waste Energy and Zedge pursue potentially dilutive equity-linked transactions. The most critical developments include Aon's transformative middle-market insurance play, BioMarin's favorable patent settlement, and the U.S. Department of War's strategic investment in Trilogy Metals, signaling government interest in critical minerals.

28 high priority 22 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 31, 2026

This morning's 50 filings reveal a market bifurcated between aggressive M&A and capital deployment by large-cap firms (Aon, SLB) and significant distress signals from smaller, cash-constrained companies (Northann, Waste Energy, Breeze Acquisition). The period-over-period data highlights a clear theme of 'growth at the expense of profitability' in the services sector, with SAIC reporting 6% revenue growth but a 20% net income decline. Insider activity is a key differentiator: bullish buys at Agree Realty and Schmid Group contrast sharply with coordinated selling at Sea Ltd, where four executives sold over $2.7M in stock under 10b5-1 plans. The forward-looking data is rich with catalysts, including multiple M&A closings in September and a major patent settlement for BioMarin that creates a new royalty stream. Capital allocation patterns are also diverging, with BBVA aggressively buying back stock while Zedge suspends its repurchase program. The most actionable intelligence centers on the Aon-USI mega-deal, the Trilogy Metals strategic investment by the Department of War, and the potential for a turnaround at Alzamend Neuro following a director's $109K insider purchase.

28 high priority 22 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 28, 2026

The August 28, 2026, filing cycle reveals a market landscape dominated by significant capital markets activity, corporate restructuring, and strategic pivots. A clear theme is the aggressive pursuit of capital through debt and equity, with companies like Karman Holdings ($100M loan), Boeing (new $2.25B facility), and Lockheed Martin ($2.25B facility) securing substantial credit lines, while smaller firms like Pluri Inc. and BranchOut Food conduct dilutive offerings. This suggests a bifurcated market where large, investment-grade companies are optimizing liquidity, while smaller, cash-strapped firms are forced into more expensive financing. The M&A landscape is active but with notable failures, as seen in the mutual termination of the Element Solutions/Solstice merger, contrasting with the successful completion of Energy Fuels' $243M acquisition of ASM and BitGo's acquisition of NYDIG's trading business. A significant risk cluster is forming around companies with distressed financials, including BioXcel Therapeutics' Chapter 11 filing, Direct Digital Holdings' repeated loan amendments, and Getty Images' $92.3M adverse judgment. Insider activity is sparse in the filings, but the executive compensation patterns at Hycroft Mining and Latch, Inc. indicate a focus on retention. The overall sentiment is cautious, with a high volume of neutral filings masking underlying financial stress and strategic realignment across sectors.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 28, 2026

This digest covers 50 filings from August 28, 2026, dominated by a surge in Nasdaq delisting and deficiency notices (11 filings), signaling a severe liquidity and compliance crisis among small-cap biotech and tech firms. The most material event is BioXcel Therapeutics' Chapter 11 bankruptcy filing with a $57.5M stalking horse bid from Teva Pharmaceuticals, creating a high-stakes auction process. In M&A, a major theme is the consolidation of the Indian cement sector via the ACC/Ambuja Cements amalgamation, alongside a significant $1.76B investment by Hero MotoCorp in EV maker Ather Energy. The SPAC sector shows continued stress, with Constellation Acquisition Corp I using its 7th extension and Allegro Merger Corp terminating its merger with SeeQC. A notable positive trend is the strong revenue growth at Cloud Wave Technologies (191% over two years) being acquired by AXISCADES, and Alara Resources Ltd's revenue surging 909% YoY, attracting investment from South West Pinnacle. Insider activity is limited in these filings, but the sheer volume of going concern and delisting risks points to a broad market cleansing event for micro-cap stocks.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 28, 2026

Today's digest reveals a market bifurcated between sectors facing headwinds and those with strong catalysts. The tanker and shipping sector is under pressure, with Hafnia Ltd reporting a 24.8% decline in net income, while the cybersecurity and AI infrastructure spaces show robust growth, exemplified by SentinelOne's 20.5% revenue increase. A significant wave of M&A and restructuring activity is reshaping the landscape, highlighted by BioXcel Therapeutics' Chapter 11 filing and BitGo's acquisition of NYDIG's trading business. Insider activity is mixed, with a notable CEO purchase in the struggling EdTech sector and routine tax-related sales at Marzetti Co. Capital allocation trends show a preference for share buybacks, with News Corp and Southern First Bancshares announcing new programs, while the IPO market shows signs of life with NorthStrive Acquisition Corp's $100M SPAC IPO. The most critical development is the NMPA approval of HUTCHMED's ATLED® for cholangiocarcinoma, a major catalyst for the biotech sector. Portfolio-level patterns indicate a defensive shift in capital allocation towards liquidity and debt management, as seen with Lockheed Martin's new credit facility and JBG SMITH's credit agreement amendment.

24 high priority 26 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 28, 2026

Overnight filings reveal a bifurcated market landscape with significant distress signals in the healthcare and technology sectors, offset by strategic capital deployment in infrastructure and energy. The most critical development is BioXcel Therapeutics' Chapter 11 filing with a stalking horse bid from Teva Pharmaceuticals, highlighting the high-risk nature of biotech. Lumentum Holdings saw a coordinated wave of insider selling by multiple top executives, including the CEO and CFO, totaling over $6.7 million, a bearish signal for the optical components sector. Conversely, a major strategic investment in VNET Group by a consortium backed by CATL signals a bullish long-term bet on Chinese data center infrastructure. Hafnia Ltd reported a 24.8% decline in net income, reflecting a challenging tanker market, while Netcapital faces a Nasdaq delisting risk due to filing delays. The overall theme is one of caution, with capital being redeployed from distressed assets into strategic long-term plays, and insider activity suggesting management concern in specific names.

36 high priority 14 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 27, 2026

The August 27, 2026, filing set reveals a market sharply bifurcated between aggressive capital markets activity and operational headwinds. A wave of SPAC mergers and IPOs (Bleichroeder/Pasqal, Southern Cross Acquisition II) signals renewed appetite for high-risk, high-reward tech and blank-check vehicles, while established companies like Build-A-Bear and Gap Inc. report declining revenues and lowered guidance, citing tariff impacts and shifting consumer demand. The most critical developments include a major $600 million credit facility for Core Scientific, a transformative $3.2 billion platform acquisition by Velocity Financial, and a high-stakes delisting deadline for SOBR Safe. Portfolio-level patterns show a pronounced divergence: growth-stage firms are aggressively accessing capital (often with dilutive terms), while mature companies are returning cash to shareholders via buybacks and dividends, even as their core operations soften. Insider activity is muted, with CFO transitions dominating personnel moves rather than conviction-based trading.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 27, 2026

The August 27, 2026, filing set is dominated by a wave of corporate actions, including a high volume of SPAC business combinations, delistings, and insolvency proceedings, creating a bifurcated market environment. A clear theme is the aggressive push into high-growth sectors like quantum computing (Bleichroeder/Pasqal), electric vehicles (Hero MotoCorp/Ather), and space technology (Black Spade/Astrum), all backed by substantial capital commitments. Conversely, a significant number of companies are facing existential threats, with multiple Nasdaq delisting notices (Lottery.com, Rein Therapeutics, SOBR Safe) and formal delistings (Forte Biosciences, Leggett & Platt) signaling a purge of non-compliant or acquired entities. The data reveals a stark contrast between capital-rich entities executing transformative deals and distressed companies struggling with regulatory compliance and financial viability. Key period-over-period trends include strong revenue growth in the EV and renewable energy sectors (Ather Energy at 44% CAGR, Florens Fresh at 95% YoY), contrasted with declining revenues at Radiance KA Sunshine Seven. Insider activity is limited but includes a notable debt forgiveness by Jupiter Neurosciences executives, signaling strong insider alignment. The forward-looking landscape is packed with catalyst-rich events, including critical NCLT hearings for Indian insolvencies and shareholder meetings for major amalgamations, providing a clear calendar for event-driven strategies.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 27, 2026

Today's filings reveal a market dominated by corporate restructuring, capital allocation shifts, and mixed earnings results. A notable theme is the significant insider selling at Sea Ltd across multiple C-suite executives, totaling over $5.4 million, which raises concerns about management conviction despite the company's strong market position. On the earnings front, a divergence is clear: Salesforce and CrowdStrike show strong revenue growth and improving profitability, while HP Inc. and Hormel Foods face margin compression from one-time charges and restructuring costs. The capital markets are active, with several companies (Eightco, Healthy Choice Wellness, Serina Therapeutics) pursuing dilutive financing strategies, while KKR faces a $250 million antitrust penalty. A major corporate control event is unfolding at Nexa Resources, with its controlling shareholder agreeing to sell its stake to Boliden. Overall, the data suggests a cautious market environment where companies are aggressively managing balance sheets and insiders are taking profits, while investors should focus on quality names with clear growth trajectories and prudent capital allocation.

23 high priority 27 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 27, 2026

This overnight filing cycle reveals a market bifurcated between strong operational performance in large-cap tech and consumer staples, and severe distress in micro-cap and pre-revenue companies. Salesforce, Okta, and HP Inc. posted double-digit revenue growth and significant margin improvements, while CrowdStrike achieved a major profitability milestone. However, this is contrasted by a wave of insider selling across sectors—including Lazard, Delek US, and Faraday Future—and alarming financial deterioration at Eightco Holdings, M2i Global, and Standard Nuclear. A notable regulatory development is KKR's $250M antitrust settlement, while the SPAC space sees continued de-SPAC activity with Plum III and Inflection Point. The most actionable themes are the divergence in capital allocation (aggressive buybacks at Salesforce vs. dilutive financing at Serina) and the concentration risk emerging in the digital asset treasury strategy at Eightco.

39 high priority 11 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 26, 2026

The August 26, 2026, filing batch reveals a market dominated by significant M&A activity and capital structure events, with 50 filings analyzed. Key themes include a major biotech licensing deal (Biohaven), a large-scale SPAC merger (Bleichroeder/Pasqal), and a transformative acquisition in the industrial sector (Somnigroup/Leggett & Platt). Period-over-period data is sparse in these 8-K filings, but forward-looking statements from Gevo (reaffirming $60M+ Adjusted EBITDA) and CuriosityStream (raised guidance) signal strong operational momentum. Insider activity is limited, but capital allocation actions like Saratoga Investment's $85M debt issuance and Cheetah Net's $35M ATM program indicate varied financing strategies. The most critical developments are the high-redeemer SPAC merger and the completion of a $2.3B all-stock acquisition, which carry significant implications for the combined entities' valuations and market positioning.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 26, 2026

The 47 filings from August 26, 2026, reveal a market sharply bifurcated between distressed entities undergoing insolvency or facing delisting, and a flurry of M&A and capital restructuring activity. A dominant theme is the wave of corporate distress in India, with Simbhaoli Sugars, Future Consumer, and SKIL Infrastructure all deep in insolvency proceedings, while American Resources Corp and Atlantic American Corp face Nasdaq delisting for delinquent filings. On the M&A front, major transactions include the $2.3B all-stock acquisition of Leggett & Platt by Somnigroup, the completion of AstroNova's take-private by Arcline, and a significant SPAC merger for Bleichroeder Acquisition Corp. II with Pasqal, though the latter saw heavy redemptions. A notable pattern is the surge in issuer tender offers from private credit and BDC funds (Blue Owl, Crescent, Brookfield), offering liquidity but often with low participation, signaling a cautious investor base. Insider activity was sparse, but the lack of insider tendering in several BDC offers suggests management confidence. The period-over-period data is most impactful in the distressed filings, where Simbhaoli Sugars' revenue collapsed 37% YoY and losses widened 13%, underscoring the severity of the insolvency. The overall picture is one of aggressive capital reallocation, with distressed assets being shed and capital flowing into strategic consolidations and private market liquidity events.

47 high priority 47 total filings
· daily

US SEC Filings Daily Market Digest — August 26, 2026

Today's filings reveal a market bifurcated between aggressive capital deployment (M&A, SPACs, buybacks) and operational headwinds (cyberattacks, supply chain constraints, revenue declines). The most significant development is the Ursa Major de-SPAC merger, a $2.3B bet on defense tech with explosive revenue growth but pre-profit status, signaling strong investor appetite for high-growth, capital-intensive sectors. Conversely, the Boston Scientific cyberattack and TORM's 25% profit decline highlight operational fragility in healthcare and cyclical weakness in shipping. A clear sector theme is the 'de-SPAC' wave, with three major transactions (Ursa Major, Gravitics, Evernorth) moving toward closure, each with distinct risk/reward profiles. Insider activity is mixed but notable, with a Webull president selling $476K and a Biohaven CLO selling $458K, contrasting with a CEO exercising options at Applied Energetics. Capital allocation trends show a preference for debt reduction (Generation Income Properties) and share repurchases (News Corp, Avalanche Treasury) over dividend growth. Overall, the digest points to a market favoring defense, space, and crypto infrastructure, while punishing companies with execution risks or cyclical exposure.

19 high priority 31 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 26, 2026

Overnight filings from August 25-26, 2026, reveal a market bifurcated between defense/space SPACs and industrial/energy companies facing cyclical headwinds. The most significant development is the Bleichroeder Acquisition Corp. III / Ursa Major de-SPAC, a $2.3B post-money valuation deal with a $350M PIPE, signaling strong institutional appetite for defense tech. Conversely, TORM plc's 25% YoY net profit decline and Donaldson's mixed results (record sales but Industrial Filtration down 2%) highlight margin pressure in cyclical sectors. Insider activity is a key theme: significant sells by CORPAY ($1.59M) and Allison Transmission ($2.94M) contrast with a massive insider purchase of Expion360 convertible debentures ($20.3B notional), suggesting a high-conviction bet on a turnaround. The Equinox Gold 13G filing from Fairfax indicates a passive, value-oriented stake in gold. Cybersecurity risk is elevated with Boston Scientific's operational disruption, while the Charter/Cox Communications deal closes, creating a cable giant. The period-over-period data shows a clear divergence: growth in defense/space (Ursa Major revenue +143% YoY) vs. contraction in shipping (TORM revenue -11.8%) and select industrials.

29 high priority 21 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 25, 2026

The August 25, 2026 filings reveal a market actively reallocating capital toward defense, AI infrastructure, and critical minerals, evidenced by major SPAC deals and strategic acquisitions in hypersonics (Ursa Major), AI power management (Navitas/Claros), and rare earths (Rare Earths Americas). Concurrently, significant debt refinancing activity across financial and industrial names (Credit Acceptance, TPG Twin Brook, Tractor Supply) indicates a focus on optimizing balance sheets amid a rising rate environment. Governance and leadership transitions are widespread, with notable departures due to misconduct (Exyn Technologies) and strategic disagreements (Core Laboratories), alongside CFO changes at major firms like Exelon and Sun Communities. Several companies are in distressed financial positions, including BioXcel and reAlpha, facing tight deadlines and regulatory hurdles. The overall sentiment is cautiously optimistic, with a clear trend toward leveraging capital markets for growth while managing leverage and liquidity.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 25, 2026

The 50 filings from August 25, 2026, paint a picture of a market with significant distress signals and capital reallocation. A dominant theme is SPAC distress, where Black Hawk, Range Capital, and DT Cloud Star are all making monthly extension payments to avoid liquidation, while Future Vision II saw a 32.4% redemption rate ($20.6M) on its latest extension. Concurrently, there is a wave of M&A in the defense and life sciences sectors with high valuations, including a $2.3B SPAC merger for Ursa Major (hypersonics) and a stock-and-cash merger between MiMedx and Sanara MedTech. The regulatory environment is exceptionally active, with SEBI issuing multiple enforcement and recovery orders for market manipulation. Nasdaq compliance issues are rampant, with Datavault AI, Fathom Holdings, BEST SPAC I, Maison Solutions, and BioRestorative all receiving delisting-deficiency notices, highlighting a broad-based crisis among micro-cap equities. On the operational side, La Rosa Holdings shows a mixed picture with gross profit growth (+9.9%) masking a revenue decline (-18%) and a significant going-concern risk. The total capital being deployed for new renewable energy investments (Arvind Limited, Shriram Pistons) totals ₹27.6 Crore, signaling a clear shift toward captive solar power. Insider activity is starkly absent across these filings, which is a negative signal, as it suggests management teams are not buying their own stock. The most actionable signal is the 41.6% operating loss improvement at La Rosa Holdings against a backdrop of insolvency risk.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 25, 2026

Today's filings reveal a market bifurcated between aggressive capital deployment and operational caution. The most significant development is the SPAC merger of Ursa Major with Bleichroeder Acquisition Corp. III, valuing a key defense tech player at $2.3B and signaling strong institutional appetite for next-gen aerospace. In the M&A space, NextEra Energy's $1.38B acquisition of Dominion Energy faces shareholder litigation, while Repligen's merger with BioLife and Navitas Semiconductor's acquisition of Claros highlight consolidation in life sciences and AI infrastructure. Consumer-facing companies like Citi Trends and Marzetti show mixed results, with top-line growth offset by margin pressure. A notable governance scandal at Exyn Technologies (CEO resignation for personal expense misuse) and a Nasdaq compliance extension for Datavault AI underscore elevated micro-cap risk. The financial sector shows steady capital returns, with Equinor's buyback and Ryman Hospitality's $700M debt issuance for a strategic acquisition. Overall, the period-over-period data reveals a 'growth at a cost' theme, with many companies sacrificing near-term profitability for market share or strategic positioning.

20 high priority 30 medium 50 total filings